BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6859963)

  • 1. A new specific assay for the detection of DNA immune complexes: its relevance in SLE.
    Klemp P; Meyers OL; Harley EH
    Ann Rheum Dis; 1983 Jun; 42(3):317-22. PubMed ID: 6859963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
    Lloyd W; Schur PH
    Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
    Harkiss GD; Hazleman BL; Brown DL
    J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus.
    McGrath H; Biundo JJ
    Arthritis Rheum; 1985 Apr; 28(4):425-30. PubMed ID: 3885960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
    Via CS; Allen RC; Welton RC
    J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus.
    Abrass CK; Nies KM; Louie JS; Border WA; Glassock RJ
    Arthritis Rheum; 1980 Mar; 23(3):273-82. PubMed ID: 6987992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Useful laboratory measurements in the management of systemic lupus erythematosus.
    Morrow WJ; Isenberg DA; Todd-Pokropek A; Parry HF; Snaith ML
    Q J Med; 1982; 51(202):125-38. PubMed ID: 6981121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies on the significance of DNA:anti-DNA complexes in the systemic circulation and cerebrospinal fluid (CSF) of patients with systemic lupus erythematosus.
    Carr RI; Harbeck RJ; Hoffman AA; Pirofsky B; Bardana EJ
    J Rheumatol; 1975 Jun; 2(2):184-93. PubMed ID: 807729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE).
    Bardana EJ; Harbeck RJ; Hoffman AA; Pirofsky B; Carr RI
    Am J Med; 1975 Oct; 59(4):515-22. PubMed ID: 1166858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
    Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
    Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
    Meryhew NL; Kimberly RP; Messner RP; Runquist OA
    J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
    Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
    Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific DNA immune complex assay, and its application in SLE.
    Harley EH; Klemp P
    Clin Chim Acta; 1982 Jul; 122(2):213-23. PubMed ID: 7105408
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA-anti-DNA complexes account for part of the antihistone activity found in patients with systemic lupus erythematosus.
    Subiza JL; Caturla A; Pascual-Salcedo D; Chamorro MJ; Gazapo E; Figueredo MA; de la Concha EG
    Arthritis Rheum; 1989 Apr; 32(4):406-12. PubMed ID: 2706026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of systemic lupus erythematosus patients with antihistone antibodies.
    Fritzler M; Ryan P; Kinsella TD
    J Rheumatol; 1982; 9(1):46-51. PubMed ID: 7086779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus glomerulonephritis in children.
    Garin EH; Shulman ST; Donnelly WH; Richard GA
    Paediatrician; 1981; 10(5-6):351-67. PubMed ID: 6460214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus.
    Bruneau CD; Edmonds JP; Hughes GR; Aarden L
    Clin Exp Immunol; 1977 Jun; 28(3):433-6. PubMed ID: 302166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.